Resolved Hypereosinophilic Syndrome and Immune Thrombocytopenic Purpura in Ulcerative Colitis Patients Post Colectomy: A Case Series and Literature Review

References

• Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140(6):1729–1737. doi:10.1053/j.gastro.2011.02.012
   PubMed Web of Science ®Google Scholar
• Rabinowitz K, Mayer L. Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol Res. 2012;54(1–3):14–24. doi:10.1007/s12026-012-8315-5
   PubMed Web of Science ®Google Scholar
• Scharl M, Rogler G. Inflammatory bowel disease pathogenesis: what is new? Curr Opin Gastroenterol. 2012;28(4):301–309. doi:10.1097/MOG.0b013e328353e61e
   PubMed Web of Science ®Google Scholar
• MacDermott RP, Nash GS, Auer IO, et al. Alterations in serum immunoglobulin g subclasses in patients with-ulcerative colitis and crohn’s disease. Gastroenterology. 1989;96(2):764–768. doi:10.1016/S0016-5085(89)80074-5
   PubMedGoogle Scholar
• Ho GT, Porter RJ, Kalla R. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Research. 2020;9. doi:10.12688/f1000research.20805.1
   PubMedGoogle Scholar
• Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med. 2011;17(11):1381–1390. doi:10.1038/nm.2514
   PubMed Web of Science ®Google Scholar
• Satsangi J, Landers CJ, Welsh KI, Koss K, Targan S, Jewell DP. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis. 2007;4(1):18–26. doi:10.1002/ibd.3780040105
   Google Scholar
• Al-Haddad S, Riddell RH. The role of eosinophils in inflammatory bowel disease. Gut. 2005;54(12):1674–1675. doi:10.1136/gut.2005.072595
   PubMed Web of Science ®Google Scholar
• Jacobs I, Ceulemans M, Wauters L, et al. Role of eosinophils in intestinal inflammation and fibrosis in inflammatory bowel disease: an overlooked villain? Front Immunol. 2021;12. doi:10.3389/fimmu.2021.754413
   Web of Science ®Google Scholar
• Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50(4):992–1006. doi:10.1016/j.immuni.2019.03.017
   PubMed Web of Science ®Google Scholar
• Graham DB, Luo C, O’Connell DJ, et al. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat Med. 2018;24(11):1762–1772. doi:10.1038/s41591-018-0203-7
   PubMed Web of Science ®Google Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3(7):521–533. doi:10.1038/nri1132
   PubMed Web of Science ®Google Scholar
• Chetri K, Aggarwal R, Sharma B, Nityanand S, Naik SR. Ulcerative colitis and immune thrombocytopenia: a report of two cases. Indian J Gastroenterol. 1999;18(4):174.
   PubMedGoogle Scholar
• Casella G, Antonelli E, Villanacci V, et al. Immune thrombocytopenia in ulcerative colitis. Tech Coloproctol. 2016;20(7):499–500. doi:10.1007/s10151-016-1471-1
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, Tomiyama Y. Pathophysiology and management of primary immune thrombocytopenia. Int J Hematol. 2013;98(1):24–33. doi:10.1007/s12185-013-1370-4
   PubMed Web of Science ®Google Scholar
• Singh A, Uzun G, Bakchoul T. Primary immune thrombocytopenia: novel insights into pathophysiology and disease management. J Clin Med. 2021;10(4):1–21. doi:10.3390/jcm10040789
   Web of Science ®Google Scholar
• Audia S, Moulinet T, Ciudad-Bonté M, et al. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia. J Autoimmun. 2018;93:139–144. doi:10.1016/j.jaut.2018.07.015
   PubMed Web of Science ®Google Scholar
• Koneru S, Koshy G, Sharp C, Khalafallah AA. Hypereosinophilic syndrome associated with ulcerative colitis presenting with recurrent Loeffler’s endocarditis and left ventricular thrombus treated successfully with immune suppressive therapy and anticoagulation. BMJ Case Rep. 2013;2013(2):bcr2013200919–bcr2013200919. doi:10.1136/bcr-2013-200919
   PubMedGoogle Scholar
• Ángel F. Case report: hypereosinophilic syndrome response to infliximab in a patient with ulcerative colitis. Gastroenterol Hepatol Open Access. 2016;5(5). doi:10.15406/ghoa.2016.05.00158
   Google Scholar
• Curtis C, Ogbogu P. Hypereosinophilic syndrome. Clin Rev Allergy Immunol. 2016;50(2):240–251. doi:10.1007/s12016-015-8506-7
   PubMed Web of Science ®Google Scholar
• Abo Shdid R, Azrieh B, Alebbi S, Mansour S, Naeem M. Idiopathic hypereosinophilic syndrome with multiple organ involvement. Case Rep Oncol. 2021;14(1):249–255. doi:10.1159/000511396
   PubMed Web of Science ®Google Scholar
• Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: current concepts and treatments. Br J Haematol. 2009;145(3):271–285. doi:10.1111/j.1365-2141.2009.07599.x
   PubMed Web of Science ®Google Scholar
• Queliza K, Ihekweazu FD, Ali A, Kellermayer R. Inflammatory bowel disease and immune thrombocytopenic purpura: combined immune dysregulation in an adolescent. Ann Clin Lab Sci. 2017;47(2):226–228.
   PubMed Web of Science ®Google Scholar
• Epistola R, Do T, Vankina R, et al. Immune thrombocytopenic purpura (ITP) as an uncommon extraintestinal complication of crohn’s disease: case vignette and systematic literature review. Case Rep Hematol. 2020;2020:1–6. doi:10.1155/2020/4785759
   Web of Science ®Google Scholar
• Awano N, Ryu T, Yoshimura N, Takazoe M, Kitamura S, Tanaka M. Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia. Intern Med. 2011;50(16):1741–1745. doi:10.2169/internalmedicine.50.5569
   PubMed Web of Science ®Google Scholar
• Fathi AT, Dec GWJ, Richter JM, et al. Case 7-2014: a 27-year-old man with diarrhea, fatigue, and eosinophilia. NEJM. 2014;370(9):861–872. doi:10.1056/NEJMCPC1302331
   PubMed Web of Science ®Google Scholar
• Herndon JS, Vitta S, Weber FH. Marked eosinophilia in a 27-year-old woman with recent onset ulcerative colitis. Gastroenterology. 2021;160(1):29–30. doi:10.1053/j.gastro.2020.08.030
   PubMed Web of Science ®Google Scholar
• Kane SP. Ulcerative colitis with chronic liver disease, eosinophilia and auto-immune thyroid disease. Postgrad Med J. 1977;53(616):105–108. doi:10.1136/pgmj.53.616.105
   PubMed Web of Science ®Google Scholar
• Zlatanic J, Korelitz BI, Wisch N, et al. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Am J Gastroenterol. 1997;92(12SUPPL):2285–2288.
   PubMedGoogle Scholar
• Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis: part II long-term prognosis. Gut. 1963;4(4):309–315. doi:10.1136/gut.4.4.309
   PubMed Web of Science ®Google Scholar
• Komeda Y, Sakurai T, Sakai K, et al. Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: a case report. World J Clin Cases. 2020;8(24):6389–6395. doi:10.12998/wjcc.v8.i24.6389
   PubMed Web of Science ®Google Scholar
• Mizuta Y, Isomoto H, Kadokawa Y, et al. Immune thrombocytopenic purpura in patients with ulcerative colitis. J Gastroenterol. 2003;38(9):884–890. doi:10.1007/s00535-002-1166-4
   PubMed Web of Science ®Google Scholar
• Chandra S, Finn S, Obah E. Immune thrombocytopenic purpura in ulcerative colitis: a case report and systematic review. J Community Hosp Intern Med Perspect. 2014;4(2):23386. doi:10.3402/jchimp.v4.23386
   PubMedGoogle Scholar
• Chan KH, Lim SL, Are G, DaCosta T, Shaaban HS, Rare A. Case of Evans syndrome in a patient with ulcerative colitis. Gastroenterol Res. 2020;13(4):158–160. doi:10.14740/gr1316
   PubMed Web of Science ®Google Scholar
• Gomez G, Umar S, Bilal M, Strahotin C, Clarke K. Febrile neutropenia with thrombocytopenia after infliximab induction in a patient with ulcerative colitis. Case Rep Gastroenterol. 2016;10(3):596–599. doi:10.1159/000448071
   PubMedGoogle Scholar
• Kwon JH, Lee C, Choi JM, et al. A case of immune thrombocytopenic purpura associated with preexisting ulcerative colitis treated with colectomy and splenectomy. Intest Res. 2013;11(4):310. doi:10.5217/ir.2013.11.4.310
   Google Scholar
• Guarina A, Barone A, Tornesello A, et al. Association of immune thrombocytopenia and inflammatory bowel disease in children. J Clin Med. 2021;10(9):1940. doi:10.3390/jcm10091940
   PubMed Web of Science ®Google Scholar
• Dehal A, Patel S, Johna S, Nguyen P. Acute ulcerative colitis, thrombocytopenia, and venous thromboembolism treated with combined laparoscopic splenectomy and colectomy. CRSLS MIS Case Reports from SLS. 2014;18(4). doi:10.4293/crsls.2014.00298
   Google Scholar
• Papadatou B, Bracci F, Knafelz D, et al. Ulcerative colitis and acute thrombocytopenia in a pediatric patient: a case report and review of the literature. Health. 2014;6(12):1497–1502. doi:10.4236/health.2014.612184
   Google Scholar
• Wang SA. The diagnostic work-up of hypereosinophilia. Pathobiology. 2019;86(1):39–52. doi:10.1159/000489341
   PubMed Web of Science ®Google Scholar
• Rauscher C, Freeman A. Drug-induced eosinophilia. Allergy Asthma Proc. 2018;39(3):252–256. doi:10.2500/aap.2018.39.4120
   PubMed Web of Science ®Google Scholar
• Barrie A, Mourabet E, Weyant K, et al. Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Dig Dis Sci. 2013;58(1):222–228. doi:10.1007/s10620-012-2329-7
   PubMed Web of Science ®Google Scholar
• Click B, Anderson AM, Koutroubakis IE, et al. Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype. Am J Gastroenterol. 2017;112(12):1849–1858. doi:10.1038/ajg.2017.402
   PubMed Web of Science ®Google Scholar
• Machicado JD, Kabbani T, Rivers CR, et al. Sa1187 peripheral blood eosinophilia in patients with inflammatory bowel disease is associated with worse outcomes: a 5-year prospective study. Gastroenterology. 2015;148(4):S251. doi:10.1016/s0016-5085(15)30827-1
   Web of Science ®Google Scholar
• Cooper N, Radia D. Thrombocytopenia. Medicine. 2021;49(4):217–220. doi:10.1016/j.mpmed.2021.01.007
   Google Scholar
• Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2012;2012:191–197. doi:10.1182/asheducation.v2012.1.191.3798260
   PubMed Web of Science ®Google Scholar
• Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol. 2014;89(3):325–337. doi:10.1002/ajh.23664
   PubMed Web of Science ®Google Scholar
• Bergua JM, Prieto-Pliego E, Román-Barberá A, et al. Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation. Ann Hematol. 2008;87(11):937–938. doi:10.1007/s00277-008-0505-9
   PubMed Web of Science ®Google Scholar
• Zabrowski D, Abraham D, Rosenthal G, Kader H. Development of peripheral eosinophilia in inflammatory bowel disease patients on infliximab treated at a tertiary pediatric inflammatory bowel disease center is associated with clinically active disease but does not result in loss of efficacy or adverse o. JGH Open. 2020;4(4):636–641. doi:10.1002/jgh3.12308
   PubMed Web of Science ®Google Scholar
• Diny NL, Rose NR, Čiháková D. Eosinophils in autoimmune diseases. Front Immunol. 2017;8. doi:10.3389/fimmu.2017.00484
   PubMed Web of Science ®Google Scholar